Nucleoside-modified circRNA: Reduced immunogenicity and expansive applications beyond vaccines
Year: 2026
Type: article
Abstract: mRNA drives the production of functional proteins to achieve therapeutic intervention, rendering it an attractive molecular platform for biomedical applications. In the 1990s, researchers established in vitro transcription (IVT) systems to produce linear mRNA encoding target proteins. Nevertheless, unmodified mRNA exhibits potent immunogenicity and elicits robust innate immune responses in vivo, which brought early translational research of mRNA to a prolonged standstill. In 2005, the Karikó and Weissman team demonstrated that replacing native uridine (U) with chemically modified pseudouridine (ψ) during IVT could drastically reduce mRNA immunogenicity and evade innate immune sensing.
Language: English
Topic: Circular RNAs in diseases
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,900
OpenAlex ID: W7208834558
